News HIV vaccine shows ‘encouraging’ early results Janssen has unveiled what it calls ‘encouraging’ early results of its vaccine to prevent infection by HIV.
News Gilead's new blockbuster HIV combination nears filing Pharma looks to file bictegravir and F/TAF later this year.
News Call for inquiry into NHS contaminated blood scandal Former health secretary says scandal was "criminal" cover-up.
News Scotland says yes to Truvada as PrEP The Scottish Medicines Consortium has approved the use of Gilead’s Truvada for use in preventing new HIV infections, so called pre-exposure prophylaxis (PrEP).
Gilead Wales experts back HIV prophlyaxis, ahead of key meetings Cost-effectiveness bodies in Wales and Scotland to decide on Truvada in April.
Gilead Gilead aims to challenge GSK's HIV drug Tivicay But GSK hit back with plans for two-drug regimen.
News Relief for AZ as Truqap hits the spot in prostate cancer After a disappointing result with Truqap in triple-negative breast cancer, AstraZeneca chalks up a win in prostate cancer
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
